Results
|
341.
|
|
|
342.
|
|
|
343.
|
|
|
344.
|
|
|
345.
|
Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non-Small-Cell Lung Cancer. [electronic resource] by
- Garon, Edward B
- Reck, Martin
- Paz-Ares, Luis
- Ponce, Santiago
- Jaime, Jesus Corral
- Juan, Oscar
- Nadal, Ernest
- Lee, Pablo
- Dalal, Rita
- Liu, Jingyi
- He, Shuang
- Treat, Joseph
- Nakagawa, Kazuhiko
Producer: 20170926
In:
Clinical lung cancer vol. 18
Availability: No items available.
|
|
346.
|
|
|
347.
|
Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L). [electronic resource] by
- Kato, Ryoji
- Hayashi, Hidetoshi
- Chiba, Yasutaka
- Miyawaki, Eriko
- Shimizu, Junichi
- Ozaki, Tomohiro
- Fujimoto, Daichi
- Toyozawa, Ryo
- Nakamura, Atsushi
- Kozuki, Toshiyuki
- Tanaka, Kentaro
- Teraoka, Shunsuke
- Usui, Kazuhiro
- Nishino, Kazumi
- Hataji, Osamu
- Ota, Keiichi
- Ebi, Noriyuki
- Saeki, Sho
- Akazawa, Yuki
- Okuno, Motoyasu
- Yamamoto, Nobuyuki
- Nakagawa, Kazuhiko
Producer: 20210526
In:
Journal for immunotherapy of cancer vol. 8
Availability: No items available.
|
|
348.
|
|
|
349.
|
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW. [electronic resource] by
- Muro, Kei
- Cho, Jae Yong
- Bodoky, Gyorgy
- Goswami, Chanchal
- Chao, Yee
- Dos Santos, Lucas V
- Shimada, Yasuhiro
- Topuzov, Eldar
- Van Cutsem, Eric
- Tabernero, Josep
- Zalcberg, John
- Chau, Ian
- Cascinu, Stefano
- Cheng, Rebecca
- Hsu, Yanzhi
- Emig, Michael
- Orlando, Mauro
- Fuchs, Charles
Producer: 20180803
In:
Journal of gastroenterology and hepatology vol. 33
Availability: No items available.
|
|
350.
|
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results. [electronic resource] by
- Reck, Martin
- Garon, Edward B
- Paz-Ares, Luis
- Ponce, Santiago
- Jaime, Jesus Corral
- Juan, Oscar
- Nadal, Ernest
- Kiura, Katsuyuki
- Widau, Ryan C
- He, Shuang
- Dalal, Rita
- Lee, Pablo
- Nakagawa, Kazuhiko
Producer: 20190308
In:
Clinical lung cancer vol. 19
Availability: No items available.
|
|
351.
|
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial. [electronic resource] by
- Ramalingam, Suresh S
- Pérol, Maurice
- Reck, Martin
- Kowalyszyn, Ruben Dario
- Gautschi, Oliver
- Kimmich, Martin
- Cho, Eun Kyung
- Czyzewicz, Grzegorz
- Grigorescu, Alexandru
- Karaseva, Nina
- Dakhil, Shaker
- Lee, Pablo
- Zimmerman, Annamaria
- Sashegyi, Andreas
- Alexandris, Ekaterine
- Carter, Gebra Cuyun
- Winfree, Katherine B
- Garon, Edward B
Producer: 20190308
In:
Clinical lung cancer vol. 19
Availability: No items available.
|
|
352.
|
RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer. [electronic resource] by
- Sorokin, Maxim
- Poddubskaya, Elena
- Baranova, Madina
- Glusker, Alex
- Kogoniya, Lali
- Markarova, Ekaterina
- Allina, Daria
- Suntsova, Maria
- Tkachev, Victor
- Garazha, Andrew
- Sekacheva, Marina
- Buzdin, Anton
Producer: 20210527
In:
Cold Spring Harbor molecular case studies vol. 6
Availability: No items available.
|
|
353.
|
|
|
354.
|
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. [electronic resource] by
- Fuchs, Charles S
- Tomasek, Jiri
- Yong, Cho Jae
- Dumitru, Filip
- Passalacqua, Rodolfo
- Goswami, Chanchal
- Safran, Howard
- Dos Santos, Lucas Vieira
- Aprile, Giuseppe
- Ferry, David R
- Melichar, Bohuslav
- Tehfe, Mustapha
- Topuzov, Eldar
- Zalcberg, John Raymond
- Chau, Ian
- Campbell, William
- Sivanandan, Choondal
- Pikiel, Joanna
- Koshiji, Minori
- Hsu, Yanzhi
- Liepa, Astra M
- Gao, Ling
- Schwartz, Jonathan D
- Tabernero, Josep
Producer: 20140123
In:
Lancet (London, England) vol. 383
Availability: No items available.
|
|
355.
|
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer. [electronic resource] by
- Mackey, John R
- Ramos-Vazquez, Manuel
- Lipatov, Oleg
- McCarthy, Nicole
- Krasnozhon, Dmitriy
- Semiglazov, Vladimir
- Manikhas, Alexey
- Gelmon, Karen A
- Konecny, Gottfried E
- Webster, Marc
- Hegg, Roberto
- Verma, Sunil
- Gorbunova, Vera
- Abi Gerges, Dany
- Thireau, Francois
- Fung, Helena
- Simms, Lorinda
- Buyse, Marc
- Ibrahim, Ayman
- Martin, Miguel
Producer: 20150316
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33
Availability: No items available.
|
|
356.
|
Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer: A hypothesis-generating study. [electronic resource] by
- Soda, Hiroshi
- Ogawara, Daiki
- Fukuda, Yuichi
- Tomono, Hiromi
- Okuno, Daisuke
- Koga, Seiko
- Taniguchi, Hirokazu
- Yoshida, Masataka
- Harada, Tatsuhiko
- Umemura, Asuka
- Yamaguchi, Hiroyuki
- Mukae, Hiroshi
Producer: 20200207
In:
Thoracic cancer vol. 10
Availability: No items available.
|
|
357.
|
|
|
358.
|
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study. [electronic resource] by
- Tabernero, J
- Hozak, R R
- Yoshino, T
- Cohn, A L
- Obermannova, R
- Bodoky, G
- Garcia-Carbonero, R
- Ciuleanu, T-E
- Portnoy, D C
- Prausová, J
- Muro, K
- Siegel, R W
- Konrad, R J
- Ouyang, H
- Melemed, S A
- Ferry, D
- Nasroulah, F
- Van Cutsem, E
Producer: 20190408
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
359.
|
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. [electronic resource] by
- Wilke, Hansjochen
- Muro, Kei
- Van Cutsem, Eric
- Oh, Sang-Cheul
- Bodoky, György
- Shimada, Yasuhiro
- Hironaka, Shuichi
- Sugimoto, Naotoshi
- Lipatov, Oleg
- Kim, Tae-You
- Cunningham, David
- Rougier, Philippe
- Komatsu, Yoshito
- Ajani, Jaffer
- Emig, Michael
- Carlesi, Roberto
- Ferry, David
- Chandrawansa, Kumari
- Schwartz, Jonathan D
- Ohtsu, Atsushi
Producer: 20150127
In:
The Lancet. Oncology vol. 15
Availability: No items available.
|
|
360.
|
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. [electronic resource] by
- Zhu, Andrew X
- Park, Joon Oh
- Ryoo, Baek-Yeol
- Yen, Chia-Jui
- Poon, Ronnie
- Pastorelli, Davide
- Blanc, Jean-Frederic
- Chung, Hyun Cheol
- Baron, Ari D
- Pfiffer, Tulio Eduardo Flesch
- Okusaka, Takuji
- Kubackova, Katerina
- Trojan, Jorg
- Sastre, Javier
- Chau, Ian
- Chang, Shao-Chun
- Abada, Paolo B
- Yang, Ling
- Schwartz, Jonathan D
- Kudo, Masatoshi
Producer: 20150928
In:
The Lancet. Oncology vol. 16
Availability: No items available.
|